CD45RC Antikörper (Biotin)
Kurzübersicht für CD45RC Antikörper (Biotin) (ABIN307978)
Target
Alle CD45RC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Spezifität
- Anti-rat CD45RC monoclonal antibody reacts with the high molecular weight form (190-240 kD) of the leukocyte common antigen designated as CD45RC. This designation includes the 240 kD form on B cells as well as a subfraction of the 190, 200 and 220 kD f.
- 
                                            Aufreinigung
- Protein G purified
- 
                                            Immunogen
- Phytohemagglutinin-activated rat lymph node cells.
- 
                                            Isotyp
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        Approved: Flo (0.1 μg/10 x106)
 Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
- 
                                            Kommentare
- 
                        Target Species of Antibody: Rat 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- Lot specific
- 
                                            Buffer
- PBS, 0.02 % sodium azide, EIA grade BSA.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - CD45RC
- 
                                            Andere Bezeichnung
- CD45RC
 Target
- 
                    
 
                                     
                                     
                                    